-
Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Promotes Siobhan Fogarty To Chief Technical Officer
04 Feb 2025 22:08 GMT
(MENAFN- Investor Brand Network)
Tonix Pharmaceuticals (NASDAQ: TNXP) announced the Promotion … leadership roles at Elan Corporation, GlaxoSmithKline, Fuisz Technologies and Biovail … press release, visit
About Tonix Pharmaceuticals Holding Corp.
Tonix is …
-
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
04 Feb 2025 12:00 GMT
… Executive Officer of Tonix Pharmaceuticals. “Her energy, insights … Ms. Fogarty moved to Glaxo SmithKline, London, as a … after the merger of Glaxo and SmithKline Beecham. … Contact Jessica Morris
Tonix Pharmaceuticals
investor.relations@tonixpharma.com
…
-
Generic Pharmaceuticals Market Poised For Strong Growth, Projected To Reach USD 740.5 Billion By 2032
04 Feb 2025 09:23 GMT
… opportunity for the generic pharmaceuticals industry. As healthcare infrastructures … To analyze the global Generic Pharmaceuticals market consumption, industry size … •Novartis AG
•Abbott Laboratories
•GlaxoSmithKline PLC
•Sun Pharmaceutical Industries Ltd …
-
Pulmonary Drug Delivery Systems Market To Achieve USD 97.8 Billion By 2033 With A CAGR Of 5.7%
05 Feb 2025 09:43 GMT
Pulmonary Drug Delivery Systems Market size is expected to be worth around USD 97.8 billion by 2033 from USD 56.2 billion in 2023, growing at a CAGR of 5.7%
NEW YORK, NY, UNITED STATES, February 5, 2025 /EINPresswire.com/ -- Report Overview
…
-
Immune Checkpoint Inhibitors Market Projected to Hit USD 230.3 Billion by 2033
05 Feb 2025 09:56 GMT
… Roche Ltd.
•Merck KGaA
•Regeneron Pharmaceuticals, Inc.
•Bristol-Myers Squibb Company … .
•Shanghai Junshi Biosciences Co., Ltd.
•GlaxoSmithKline plc
Regional Analysis:
• North America …
-
Small Molecule Drug Discovery Market Growth Expected to Reach USD 121.8 Billion by 2033
05 Feb 2025 09:23 GMT
The Small Molecule Drug Discovery Market size is expected to be worth around USD 121.8 billion by 2033 from USD 52.5 billion in 2023, growing at a CAGR of 8.8%
NEW YORK CITY, NY, INDIA, February 5, 2025 /EINPresswire.com/ -- Report Overview
…
-
In-Depth Analysis Of The Global Nucala Market: Key Drivers, Trends, Growth Opportunities, And Forecast 2025-2034
05 Feb 2025 06:40 GMT
The Business Research Company's Nucala Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, February 5, 2025 /EINPresswire.com/ -- The nucala market size has seen substantial …
-
Clinical Perspective on Newly Approved Combination Therapy for Migraine: Richard B. Lipton, MD
05 Feb 2025 01:03 GMT
WATCH TIME: 5 minutes
"In treatment-refractory patients, the combination product produces excellent 2-hour pain freedom and freedom from the most bothersome symptom, corresponding to an early onset of action but also sustained benefits."
AXS-07 ( …
-
Influenza Vaccines Market Global Forecast and Company Analysis 2025-2032, with GlaxoSmithKline, Sanofi, CSL Seqirus, AstraZeneca, Gamma Vaccines, Hualan Bioengineering, Viatris and BioDiem - ResearchAndMarkets.com
29 Jan 2025 13:32 GMT
… instance, in March 2024, Cadila Pharmaceuticals, India launched Cadiflu Tetra Vaccine … Market - Key Company Analysis
GlaxoSmithKline
Sanofi
CSL Seqirus
AstraZeneca
Gamma … Key Company Analysis
11.1 GlaxoSmithKline (GSK)
11.2 Sanofi
11 …
About
© 1995-2025